NCT00695903: Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia |
|
|
| Terminated | 2 | 38 | US | daptomycin, Cubicin, daptomycin for injection, vancomycin, vancocin | Cubist Pharmaceuticals LLC | Endocarditis, Bacterial, Infective Endocarditis | 08/10 | 10/10 | | |
